Absci

Absci Corporation, a generative AI drug discovery and development company, announced on January 8 that it has entered into a strategic partnership with AMD to deploy AMD Instinct gas pedals and ROCm software to support key AI drug discovery and development workloads, including Absci's from-scratch antibody design models.AMD will also invest $20 million (currently approximately Rs. 147 crores) in Absci in the form of a private investment in equity (PIPE). AMD will also invest $20 million in Absci in the form of a private equity investment (PIPE) (I note: currently approximately RMB 147 million). Absci says this shows that in drug...

British-Swedish pharmaceutical company AstraZeneca has signed a deal worth up to $247 million with U.S.-based artificial intelligence (AI) biologics company Absci to design an antibody for use against cancer, Absci said in a statement on Sunday. Absci's collaboration with AstraZeneca aims to develop a zero-generation AI model that is designed to create new and improved antibody therapeutics. The company did not specify which types of cancer they plan to target. Absci applies generative AI design based on target affinity, safety, manufacturability and its...